Galakatos Nicholas

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Galakatos Nicholas
CIK #0001252522
EDGAR Form CIK 2011 - 2026
3 [0001252522]
4 [0001252522]
Form 3/4/5 Subject 2011 - 2026
Galakatos Nicholas
Tourmaline Bio Inc
Praxis Precision Medicines Inc
Entasis Therapeutics Holdings Inc
NanoString Technologies Inc
Simon Nicholas
Requadt Scott
Clarus Lifesciences III LP
Henner Dennis
Liptak Robert
Wheeler Kurt
Clarus Ventures III LLC
Forty Seven Inc
Clarus Ventures III GP LP
Clarus Lifesciences II LP
Clarus Ventures II LLC
Venus Concept Inc
Clarus Ventures II GP LP
Radius Health Inc
Simon Nicholas J III
Catabasis Pharmaceuticals Inc
Tetralogic Pharmaceuticals Corp
Steinmetz Michael
Project Sage Oldco Inc
Clarus Ventures I Management LP
Clarus Ventures I LLC
Clarus Lifesciences I LP
IVERIC bio Inc
Oxford Immunotec Global PLC
Aerie Pharmaceuticals Inc
Portola Pharmaceuticals Inc
Globus Medical Inc
Evnin Luke
Humanigen Inc
Gadicke Ansbert
Pernix Sleep Inc
Achillion Pharmaceuticals Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Entasis Therapeutics Holdings Inc ETTX
Stock Option (Right to Buy) · derivative
2019-06-19 Grant 7,500 $0.00
NanoString Technologies Inc NSTG
Common Stock · derivative
2019-03-25 Grant 4,410 $0.00
Entasis Therapeutics Holdings Inc ETTX
Stock Option (right to buy) · derivative
2019-01-18 Grant 15,000 $0.00
Entasis Therapeutics Holdings Inc ETTX
Common Stock
2018-09-28 Conversion 412,583
Entasis Therapeutics Holdings Inc ETTX
Common Stock
2018-09-28 Buy 453,395 $15.00 6,800,925
Entasis Therapeutics Holdings Inc ETTX
Common Stock
2018-09-28 Conversion 361,829
Entasis Therapeutics Holdings Inc ETTX
Common Stock
2018-09-28 Conversion 323,341
Entasis Therapeutics Holdings Inc ETTX
Series B Convertible Preferred Stock · derivative
2018-09-28 Conversion 7,500,000 $0.00
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche B Convertible Preferred Stock · derivative
2018-09-28 Conversion 8,552,024 $0.00
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche A Convertible Preferred Stock · derivative
2018-09-28 Conversion 6,702,213 $0.00
NanoString Technologies Inc NSTG
Common Stock
2018-09-17 Option exercise 162,408 $8.45 1,372,348
NanoString Technologies Inc NSTG
Common Stock
2018-09-17 Sell 85,823 $15.99 1,372,310
NanoString Technologies Inc NSTG
Common Stock Warrant (Right to Buy) · derivative
2018-09-17 Option exercise 162,408 $0.00
Forty Seven Inc FTSV
Common Stock
2018-07-02 Conversion 938,489
Forty Seven Inc FTSV
Common Stock
2018-07-02 Conversion 755,780
Forty Seven Inc FTSV
Common Stock
2018-07-02 Buy 200,000 $16.00 3,200,000
Forty Seven Inc FTSV
Common Stock
2018-07-02 Conversion 1,922,682
Forty Seven Inc FTSV
Series B Preferred Stock · derivative
2018-07-02 Conversion 1,922,682
Forty Seven Inc FTSV
Series A-1 Preferred Stock · derivative
2018-07-02 Conversion 938,489
Forty Seven Inc FTSV
Series A-2 Preferred Stock · derivative
2018-07-02 Conversion 755,780
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com